Loss of p53 Attenuates the Contribution of IL-6 Deletion on Suppressed Tumor Progression and Extended Survival in Kras-Driven Murine Lung Cancer

Interleukin-6 (IL-6) is involved in lung cancer tumorigenesis, tumor progression, metastasis, and drug resistance. Previous studies show that blockade of IL-6 signaling can inhibit tumor growth and increase drug sensitivity in mouse models. Clinical trials in non-small cell lung cancer (NSCLC) revea...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Xiaohong, Carretero, Julian, Chen, Zhao, Zhang, Jishuai, Wang, Yanxiao, Chen, Jicheng, Li, Xiubin, Ye, Hui, Tang, Chuanhao, Cheng, Xuan, Hou, Ning, Yang, Xiao, Wong, Kwok-Kin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829911/
https://www.ncbi.nlm.nih.gov/pubmed/24260500
http://dx.doi.org/10.1371/journal.pone.0080885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3829911/
https://www.ncbi.nlm.nih.gov/pubmed/24260500
http://dx.doi.org/10.1371/journal.pone.0080885

Ejemplares similares